Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide
THE SO WHAT
The GLP-1 gray market is maturing fast enough that Eli Lilly is litigating retatrutide before full rollout, which tells you how big they expect the category to be. Health systems and payers should plan for parallel supply chains—official and compounded—and the compliance, safety, and pricing friction that comes with them.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging TechAI Boom Fuels Warehouse Demand
The AI buildout is now spilling into ordinary industrial real estate—cooling gear, chip manufacturing, and supporting infra are filling warehouses, not just data centers. If you rely on logistics or light manufacturing space, expect tighter supply and rising rents near power and fiber, and lock in key leases earlier than your old playbook assumed.
Deep & Emerging TechLumentum’s stock surges, giving a further boost to the optical-networking trade
Lumentum’s pop and the broader optical trade strength point to markets pricing in sustained demand for high-bandwidth links — AI and cloud traffic are the backdrop. If you run infra-heavy products, expect optical capacity and vendor relationships to become a more explicit part of your cost and risk planning.
Deep & Emerging TechZoom fixed three bugs that let anyone on a call take over your machine
Zero-click RCE via Zoom’s annotation feature — now patched — shows collaboration tools are effectively part of your endpoint attack surface. If you rely on embedded AI or rich media in conferencing, treat feature toggles and permissions as security controls, not just UX settings.
Deep & Emerging TechMarten Transport notes better operating environment for segments
Marten’s improving truckload operating ratio hints that freight conditions are stabilizing, which typically precedes renewed investment in efficiency tech. If you sell into trucking, this is a window to push automation, routing, and telematics upgrades while operators have both margin and motivation.